Despite their benefits, partnerships in cancer research and treatment face several challenges. These include differences in regulatory environments, intellectual property concerns, and funding limitations. Effective communication and clear agreements are essential to overcoming these obstacles. Additionally, aligning the goals and expectations of diverse stakeholders can be complex but is crucial for the success of collaborative efforts.
